Liver enzyme elevation after 177 Lu-PSMA radioligand therapy for metastasized castration-resistant prostate cancer
2021 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Liver enzyme elevation after 177 Lu-PSMA radioligand therapy for metastasized castration-resistant prostate cancer
Treiber, H.; Koenig, A.; Neesse, A.; Richter, A.; Sahlmann, C. O. & Strauss, A. (2021)
Journal of Nuclear Medicine, pp. jnumed.120.258533. DOI: https://doi.org/10.2967/jnumed.120.258533
